37 results on '"Saul, Allan"'
Search Results
2. The transfer and decay of maternal antibody against Shigella sonnei in a longitudinal cohort of Vietnamese infants
3. Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations
4. Design of a Phase III cluster randomized trial to assess the efficacy and safety of a malaria transmission blocking vaccine
5. Simplified low-cost production of O-antigen from Salmonella Typhimurium Generalized Modules for Membrane Antigens (GMMA)
6. A broadly-protective vaccine against meningococcal disease in sub-Saharan Africa based on Generalized Modules for Membrane Antigens (GMMA)
7. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials
8. Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of responders
9. Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines
10. Enhanced antibody production in mice to the malaria antigen AMA1 by CPG 7909 requires physical association of CpG and antigen
11. Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: A strategy for enhancing immunogenicity of malaria vaccine candidates
12. The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials
13. Enhancement of functional antibody responses to AMA1-C1/Alhydrogel ®, a Plasmodium falciparum malaria vaccine, with CpG oligodeoxynucleotide
14. Revisiting Freund's incomplete adjuvant for vaccines in the developing world
15. Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria
16. Models of Phase 1 vaccine trials: optimization of trial design to minimize risks of multiple serious adverse events
17. A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant
18. Montanide ® ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations
19. Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children
20. Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum
21. Prioritizing vaccines for developing world diseases
22. Antibodies to Plasmodium vivax transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 do not show synergism
23. Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea
24. Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers
25. Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agents
26. Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant
27. Potency assay design for adjuvanted recombinant proteins as malaria vaccines
28. Aotus New World monkeys: model for studying malaria-induced anemia
29. A rapid method of concentrating proteins in small volumes with high recovery using sephadex G-25
30. Electrophoretic identification of fusion proteins expressed in single recombinant λ-bacteriophage plaques
31. Human erythrocyte Band-3 has an altered N terminus in malaria-resistant Melanesion ovalocytosis
32. Selection of an adjuvant for vaccination with the malaria antigen, MSA-2
33. Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720
34. Effect of context and adjuvant on the immunogenicity of recombinant proteins and peptide conjugates derived from the polymorphic malarial surface antigen MSA2
35. Mapping of conformational B cell epitopes within alpha-helical coiled coil proteins
36. Refractoriness of erythrocytes infected with Plasmodium falciparum gametocytes to lysis by sorbitol
37. Risk factors for malaria transmission in a hypoendemic malarious community in Bataan, the Philippines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.